Mainstream

Profound medical targets 70–75% revenue growth in 2025 as tulsa ai and captain trial progress fuel confidence

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

Post Contentprn:ca, profRead More

You might also be interested in reading Number of Solana (SOL) Transactions Approaches 100 Billion Despite The Rough 2022.

August 15, 2025
In Mainstream